Two new studies estimate psychedelic use in the U.S. and both find magic mushrooms gaining in popularity, including some folks who just want to get a little bit high, aka microdosing.
The new development on Macon’s east side, called the Tiny Cottages, are exclusively available to people who meet the federal definition of homelessness.
After a while, even the most exciting relationships, jobs and environments lose their spark. But cognitive neuroscientist Tali Sharot says it's possible to fall back in love with life's small joys.
A new study finds people who are resilient in the face of stressful events have a different mix of microorganisms in the gut than those who get more frazzled.
At a celebration against a backdrop of construction, Georgia providers said once the facility is built, it will be one step in a new proposed continuum of care.
Teachers at Roswell High School allow students to leave class for therapy appointments and return without missing a beat because teachers know that if the student is struggling with mental health, they're not going to be able to focus on math or science, school social worker Valerie Rogers says.
The FDA will review data to decide whether to approve MDMA, also known as ecstasy, for PTSD treatment. Biden is expected to issue an executive order addressing asylum seekers at the southern border.
People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research. But serious allegations of research misconduct may derail the approval timeline.
NPR science reporter Will Stone talks to host Emily Kwong about the clinical trials on MDMA-assisted therapy research and a recent report questioning the validity of the results.